drugset / Trial / NCT02241772

A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

NCT02241772

Phase 1/2 Completed 42 enrolled Xention Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study in males and females with elevated Lp(a) to look at the effects of TA-8995 on Lp(a) levels.

Timeline

Start
2014-09
Primary completion
2015-01
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Obicetrapib Small molecule 2.5 mg
Subject Obicetrapib Small molecule 10 mg